Esmaeil Mehraeen

Dr. Esmaeil Mehraeen

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
PDF file
Omid DadrasOmid Dadras
Omid Dadras
AAAmir M. Afsahi
Amir M. Afsahi
ZPZahra Pashaei
Zahra Pashaei
HMHengameh Mojdeganlou
Hengameh Mojdeganlou
AKAmirali Karimi
Amirali Karimi
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
Introduction: Patients with COVID‐19 may present different viral loads levels. However, the relationship between viral load and disease severity in COVID‐19 is still unknown. Therefore, this study aimed to systematically review the association between SARS‐CoV‐2 viral load and COVID‐19 severity.Methods: The relevant studies using the keywords of “COVID‐19” and “viral load” were searched in the databases of PubMed, Scopus, Google Scholar, and Web of Science. A two‐step title/abstract screening process was carried out and the eligible studies were included in the study.Results: Thirty‐four studies were included from the initial 1015 records. The vast majority of studies have utilized real‐time reverse transcription‐polymerase chain reaction of the nasopharyngeal/respiratory swabs to report viral load. Viral loads were commonly reported either as cycle threshold (Ct) or log10 RNA copies/ml.Conclusion: The results were inconclusive about the relationship between COVID‐19 severity and viral load, as a similar number of studies either approved or opposed this hypothesis. However, the studies denote the direct relationship between older age and higher SARS‐CoV‐2 viral load, which is a known risk factor for COVID‐19 mortality. The higher viral load in older patients may serve as a mechanism for any possible relationships between COVID‐19 viral load and disease severity. There was a positive correlation between SARS‐CoV‐2 viral load and its transmissibility. Nonetheless, further studies are recommended to precisely characterize this matter.

1 August 2021 in Journal of Medicine and Life
Verified
Journal Article
Open access
MMMohammad Mehrtak
Mohammad Mehrtak
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
MMMehrzad MohsseniPour
Mehrzad MohsseniPour
TNTayebeh Noori
Tayebeh Noori
AKAmirali Karimi
Amirali Karimi
Omid DadrasOmid Dadras
Omid Dadras
Cloud computing is among the most beneficial solutions to digital problems. Security is one of the focal issues in cloud computing technology, and this study aims at investigating security issues of cloud computing and their probable solutions. A systematic review was performed using Scopus, Pubmed, Science Direct, and Web of Science databases. Once the title and abstract were evaluated, the quality of studies was assessed in order to choose the most relevant according to exclusion and inclusion criteria. Then, the full texts of studies selected were read thoroughly to extract the necessary results. According to the review, data security, availability, and integrity, as well as information confidentiality and network security, were the major challenges in cloud security. Further, data encryption, authentication, and classification, besides application programming interfaces (API), were security solutions to cloud infrastructure. Data encryption could be applied to store and retrieve data from the cloud in order to provide secure communication. Besides, several central challenges, which make the cloud security engineering process problematic, have been considered in this study.

23 May 2022 in Health Science Reports
Verified
Journal Article
Open access
Omid DadrasOmid Dadras
Omid Dadras
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
AKAmirali Karimi
Amirali Karimi
ASAhmadreza Shamsabadi
Ahmadreza Shamsabadi
KQKowsar Qaderi
Kowsar Qaderi
FVFabrício A. Voltarelli
Fabrício A. Voltarelli
Background and Aims: Older people have higher rates of comorbidities and may experience more severe inflammatory responses; therefore, are at higher risk of death. Herein, we aimed to systematically review the mortality in coronavirus disease 2019 (COVID‐19) patients and its predictors in this age group.Methods: We searched PubMed, Web of Science, and Science Direct using relevant keywords. Retrieved records underwent a two‐step screening process consisting of title/abstract and full‐text screenings to identify the eligible studies.Results: Summarizing findings of 35 studies demonstrated that older patients have higher mortality rates compared to the younger population. A review of articles revealed that increasing age, body mass index, a male gender, dementia, impairment or dependency in daily activities, presence of consolidations on chest X‐ray, hypoxemic respiratory failure, and lower oxygen saturation at admission were risk factors for death. High d‐dimer levels, 25‐hydroxy vitamin D serum deficiencies, high C‐reactive protein (≥5 mg/L) levels plus any other abnormalities of lymphocyte, higher blood urea nitrogen or lactate dehydrogenase, and higher platelet count were predictors of poor prognosis and mortality in the elderly. Studies have also shown that previous treatment with renin–angiotensin–aldosterone system inhibitors, pharmacological treatments of respiratory disorders, antibiotics, corticosteroids, vitamin K antagonist, antihistamines, azithromycin, Itolizumab (an anti‐CD6 monoclonal antibody) in combination with other antivirals reduces COVID‐19 worsening and mortality. Vaccination against seasonal influenza might also reduce COVID‐19 mortality.Conclusion: Overall, a critical consideration is necessary for the care and management of COVID‐19 in the aged population considering the drastic contrasts in manifestation and prognosis compared to other age groups. Mortality from COVID‐19 is independently associated with the patient's age. Elderly patients with COVID‐19 are more vulnerable to poor outcomes. Thus, strict preventive measures, timely diagnosis, and aggressive therapeutic/nontherapeutic care are of great importance to reduce acute respiratory distress syndrome and severe complications in older people.

18 February 2022 in Health Science Reports
Verified
Journal Article
Open access
PDF file
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
AKAmirali Karimi
Amirali Karimi
HMHengameh Mojdeganlou
Hengameh Mojdeganlou
SASanam Alilou
Sanam Alilou
SMSeyed Peyman Mirghaderi
Seyed Peyman Mirghaderi
JSJean‐Marc Sabatier
Jean‐Marc Sabatier
Background and Aims: Scientists and healthcare workers have expressed their concerns on the impacts of the COVID‐19 pandemic on vaccination coverage in children and adolescents. Therefore, we aimed to systematically review the studies addressing this issue worldwide.Methods: We conducted a systematic search of relevant studies using the keywords on databases of PubMed, Web of Science, and Cochrane on May 22, 2021. The identified records were imported into EndNote software and underwent a two‐phase screening process consisting of title/abstract and full‐text screenings against inclusion criteria. The data of the included studies were summarized into a table and the findings were analyzed in a systematic approach.Results: From 26 eligible studies, 21 studies demonstrated decreased vaccination rates in the children during the COVID‐19 pandemic, while three studies found increased or no significant changes only in influenza vaccination. The two remaining studies from Brazil and Sweden also showed no significant changes in vaccination rates in the children during the pandemic.Conclusion: Most of the reports worldwide reported a decline or delay in vaccination at the time of the COVID‐19 pandemic. A sustained catch‐up program seems to be necessary, especially in low‐income countries, to avoid any vaccine dose missing. Facilitating the vaccination process is recommended, such as decreasing the waiting time for vaccination at the health center, addressing the fear and concerns related to COVID infection for parents, and enhancing vaccine availability, and promoting access in remote areas. Countries should ensure proper vaccination to prevent future pandemics related to vaccine‐preventable diseases.

17 June 2020 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
EMEsmaeil Mehraeen
Esmaeil Mehraeen
FBFarzane Behnezhad
Farzane Behnezhad
MSMohammad Amin Salehi
Mohammad Amin Salehi
TNTayebeh Noori
Tayebeh Noori
HHHamid Harandi
Hamid Harandi
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi

6 January 2023 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
PMPegah Mirzapour
Pegah Mirzapour
ZPZahra Pashaei
Zahra Pashaei
AAArian Afzalian
Arian Afzalian
MTMarcarious M. Tantuoyir
Marcarious M. Tantuoyir
Omid DadrasOmid Dadras
Omid Dadras
Introduction: The COVID-19 epidemic and various control and mitigation measures to combat the widespread outbreak of the disease may affect other parts of health care systems. There is a concern that the COVID-19 pandemic could disrupt HIV services. Therefore, this study aimed to systematically evaluate the effect of the COVID-19 pandemic on service delivery and treatment outcomes in people with HIV.Methods: In this study, a systematic search was conducted using the keywords in the online databases including Scopus, PubMed, Web of Science, and Cochrane databases. The retrieved articles underwent a two-step title/abstract and full-text review process, and the eligible papers were selected and included in the qualitative synthesis.Result: We selected 16 studies out of 529 retrieved records that met the inclusion criteria for this review. Study populations of the selected studies were either HIV-positive patients or HIV clinics and healthcare providers. Most studies were focused on adhering to and obtaining medication and attending clinical appointments and their decrement during the pandemic. Other aspects of HIV care (alternative healthcare settings, viral suppression, psychological care, etc.) were discussed to a lesser extent by the included studies.Conclusion: Interruption in in-person visits and medical follow-up services, loss of adherence to treatment, and subsequent increase in mortality due to the COVID-19 pandemic complications in PLHIV have led to growing concerns. Other challenges were psychological disorders such as anxiety and depression, an increase in substance abuse, and a rise in experienced stigma and discrimination. However, the use of telemedicine in some countries helps to alleviate the situation to some extent and is recommended in similar settings in the future.